Jay Donovan Wu

Insider Reports History

Location
Hellerup
Signature
/s/ Michael Wolff Jensen as attorney-in-fact for Jay Wu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jay Donovan Wu:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ascendis Pharma A/S EVP & President US Market Ordinary Shares 1,068 $250,969 $234.99 18 Mar 2026 Direct

Insider Reports Filed by Jay Donovan Wu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ASND Ascendis Pharma A/S 18 Mar 2026 0 $0 3 EVP & President US Market 18 Mar 2026, 18:06